Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.200
+0.160 (3.96%)
At close: Oct 31, 2025, 4:00 PM EDT
4.140
-0.060 (-1.43%)
After-hours: Oct 31, 2025, 7:45 PM EDT
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $29.37 million as of October 31, 2025. Its market cap has increased by 63.18% in one year.
Market Cap
29.37M
Enterprise Value
74.12M
1-Year Change
63.18%
Ranking
Category
Stock Price
$4.20
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $29.37M, a decrease of -73.44%. That is a compound annual growth rate of -11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 29.60M | 90.97% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |